UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Breast cancer therapy in China: Introducing the Special Collection

Cancer, 2024-04, Vol.130 (S8), p.1368-1370

2024

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?

Cancer, 2021-09, Vol.127 (18), p.3302-3309

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies

Cancer, 2020-08, Vol.126 (15), p.3400-3416

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting forkhead box M1 transcription factor in breast cancer

Biochemical pharmacology, 2018-08, Vol.154, p.407-413

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers

Breast cancer research and treatment, 2012-08, Vol.135 (1), p.39-48

2012

Link zum Volltext

Verfügbarkeit prüfen

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer?

Cancer, 2019-01, Vol.125 (2), p.177-180

2019

Link zum Volltext

Verfügbarkeit prüfen

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Cancer, 2018-12, Vol.124 (24), p.4618-4621

2018

Link zum Volltext

Verfügbarkeit prüfen

When the personal becomes political: The impact of the Dobbs decision on women with cancer

Cancer, 2023-01, Vol.129 (2), p.171-174

2023

Link zum Volltext

Verfügbarkeit prüfen

Progress in breast cancer research amid the COVID‐19 gloom

Cancer, 2020-08, Vol.126 (S16), p.3809-3810

2020

Link zum Volltext

Verfügbarkeit prüfen

Emerging use of nanoparticles in diagnosis and treatment of breast cancer

The lancet oncology, 2006-08, Vol.7 (8), p.657-667

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (18), p.5045-5056

2014

Link zum Volltext

Verfügbarkeit prüfen

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9712-9722

2008

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer

Molecular cancer therapeutics, 2021-12, Vol.20 (12), p.2553-2567

2021

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2479-2488

2008

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach?

Cancer, 2015-02, Vol.121 (4), p.517-526

2015

Link zum Volltext

Verfügbarkeit prüfen

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (5), p.982-993

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

Breast cancer research and treatment, 2013-10, Vol.141 (3), p.437-446

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance

Anti-cancer agents in medicinal chemistry, 2012-02, Vol.12 (2), p.151

2012

Link zum Volltext

Verfügbarkeit prüfen

Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells

Molecular cancer therapeutics, 2011-08, Vol.10 (8), p.1460-1469

2011

Link zum Volltext

Verfügbarkeit prüfen

Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1142-1146

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)

Cancer medicine (Malden, MA), 2022-11, Vol.11 (21), p.3969-3981

2022

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma

The Journal of biological chemistry, 2012-07, Vol.287 (30), p.25230-25240

2012

Link zum Volltext

Verfügbarkeit prüfen

Using a Neoadjuvant Approach for Evaluating Novel Therapies for Patients With Breast Cancer

American Society of Clinical Oncology educational book, 2018-05, Vol.38 (38), p.47-55

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Clinical breast cancer, 2019-06, Vol.19 (3), p.188-196

2019

Link zum Volltext

Verfügbarkeit prüfen

Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging

Journal of the American Chemical Society, 2008-07, Vol.130 (28), p.9006-9012

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(137)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Breast cancer therapy in China: Introducing the Special Collection

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies

Targeting forkhead box M1 transcription factor in breast cancer

Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer?

Social media and clinical trials: The pros and cons gain context when the patient is at the center

When the personal becomes political: The impact of the Dobbs decision on women with cancer

Progress in breast cancer research amid the COVID‐19 gloom

Emerging use of nanoparticles in diagnosis and treatment of breast cancer

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach?

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy

Pharmacologic inhibition of mTOR improves lapatinib sensitivity in HER2-overexpressing breast cancer cells with primary trastuzumab resistance

Combinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cells

Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition

A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)

Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma

Using a Neoadjuvant Approach for Evaluating Novel Therapies for Patients With Breast Cancer

Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging

Suchergebnisse filtern